Ye, C., Yan, C., Bian, S., Li, X., Li, Y., Wang, K., . . . Luo, L. (2024). Momordica charantia L.-derived exosome-like nanovesicles stabilize p62 expression to ameliorate doxorubicin cardiotoxicity. Journal of Nanobiotechnology, 22(1), 1. https://doi.org/10.1186/s12951-024-02705-z
Chicago Style (17th ed.) CitationYe, Cong, et al. "Momordica Charantia L.-derived Exosome-like Nanovesicles Stabilize P62 Expression to Ameliorate Doxorubicin Cardiotoxicity." Journal of Nanobiotechnology 22, no. 1 (2024): 1. https://doi.org/10.1186/s12951-024-02705-z.
MLA (9th ed.) CitationYe, Cong, et al. "Momordica Charantia L.-derived Exosome-like Nanovesicles Stabilize P62 Expression to Ameliorate Doxorubicin Cardiotoxicity." Journal of Nanobiotechnology, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12951-024-02705-z.